文献速递血液净化与透析

稳态葡萄糖浓度腹膜透析对超滤量和钠清除的影响:一项先导性交叉试验

Effects of Steady Glucose Concentration Peritoneal Dialysis on Ultrafiltration Volume and Sodium Removal: A Pilot Crossover Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-10-30

该先导性交叉试验在8例稳定腹膜透析患者中比较稳态浓度腹膜透析与标准CAPD留腹的超滤率和钠清除。稳态浓度腹膜透析使用Carry Life UF装置,三个葡萄糖剂量(11、14、20 g/h)的超滤率均显著高于对照,11 g/h剂量葡萄糖超滤效率最高。结论认为稳态浓度腹膜透析可提高超滤率、葡萄糖利用效率和钠清除。

要点

  • 稳态浓度腹膜透析三个葡萄糖剂量超滤率均显著高于标准2.5%葡萄糖CAPD留腹。
  • 11 g/h葡萄糖剂量在稳态浓度腹膜透析中葡萄糖超滤效率最高。
  • 稳态浓度腹膜透析钠清除显著高于标准CAPD留腹。

核心结论

  • 使用Carry Life UF装置行稳态浓度腹膜透析,与标准2.5%葡萄糖CAPD留腹相比,超滤率更高、葡萄糖利用更高效(每克葡萄糖吸收产生的超滤量增加)、钠清除更多。

研究设计与样本

  • 先导性交叉试验,纳入8例稳定腹膜透析患者(6例快速转运体、2例快速平均转运体),每例接受4次研究:1次标准4小时CAPD留腹(2 L 2.5%葡萄糖溶液)作为对照,3次5小时稳态浓度腹膜透析(葡萄糖剂量11、14、20 g/h,初始灌注1.5 L 1.5%葡萄糖溶液)。
  • 所有研究前均先进行过夜2 L 7.5%艾考糊精留腹。

主要发现

  • 稳态浓度腹膜透析治疗最初1-2小时腹腔内葡萄糖浓度升高,此后保持稳定。
  • 超滤率在稳态浓度腹膜透析11、14、20 g/h组分别为124±49、146±63、168±78 mL/h,均显著高于对照组的40±60 mL/h。
  • 稳态浓度腹膜透析的钠清除和葡萄糖超滤效率(超滤量/克葡萄糖摄取)均显著高于对照留腹,其中11 g/h葡萄糖剂量效率最高。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Volume overload is common in patients treated with peritoneal dialysis (PD) and is associated with poor clinical outcome. Steady concentration PD is where a continuous glucose infusion maintains the intraperitoneal glucose concentration and as a result provides continuous ultrafiltration throughout the dwell. The primary objective of this study was to investigate the ultrafiltration rate and glucose ultrafiltration efficiency for steady concentration PD in comparison with a standard continuous ambulatory PD (CAPD) dwell, using the novel Carry Life UF device. METHODS: Eight stable patients treated with PD (six fast and two fast average transporters) were investigated four times: a standard 4-hour CAPD dwell with 2 L of 2.5% dextrose solution as control and three 5-hour steady concentration PD treatments (glucose dose 11, 14, 20 g/h, initial fill 1.5 L of 1.5% dextrose solution). All investigations were preceded by an overnight 2 L 7.5% icodextrin dwell. RESULTS: Intraperitoneal glucose concentration increased during the first 1-2 hours of the steady concentration PD treatments and remained stable thereafter. Ultrafiltration rates were significantly higher with steady concentration PD treatments (124±49, 146±63, and 168±78 mL/h with 11, 14, and 20 g/h, respectively, versus 40±60 mL/h with the control dwell). Sodium removal and glucose ultrafiltration efficiency (ultrafiltration volume/gram glucose uptake) were significantly higher with steady concentration PD treatments versus the control dwell, where the 11 g/h glucose dose was most efficient. CONCLUSIONS: Steady concentration PD performed with the Carry Life UF device resulted in higher ultrafiltration rates, more efficient use of glucose (increased ultrafiltration volume/gram glucose absorbed), and greater sodium removal compared with a standard 2.5% dextrose CAPD dwell. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life ® UF, NCT03724682 .

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Heimbürger O, Hegbrant J, Martus G, et al. Effects of Steady Glucose Concentration Peritoneal Dialysis on Ultrafiltration Volume and Sodium Removal: A Pilot Crossover Trial. Clin J Am Soc Nephrol. 2023. PMID: 37902732. doi:10.2215/CJN.0000000000000342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。